US Stock MarketDetailed Quotes
VERV Verve Therapeutics
- 6.010
- -0.350-5.50%
Close May 10 16:00 ET
- 6.200
- +0.190+3.16%
Pre 08:00 ET
504.63MMarket Cap-2094P/E (TTM)
6.430High5.880Low1.60MVolume6.320Open6.360Pre Close9.70MTurnover2.39%Turnover RatioLossP/E (Static)83.97MShares21.42052wk High0.87P/B404.00MFloat Cap5.84052wk Low--Dividend TTM67.22MShs Float78.000Historical High--Div YieldTTM8.65%Amplitude5.840Historical Low6.043Avg Price1Lot Size
Verve Therapeutics News
Verve Therapeutics | 10-Q: Quarterly report
Verve Therapeutics | 10-K: Annual report
Verve Therapeutics: Q3 2023 Earnings Report
Verve Therapeutics | 10-Q: Q2 2023 Earnings Report
Verve Therapeutics | 10-Q: Q1 2023 Earnings Report
Verve Therapeutics: FY2022 Annual Report
10-K | Verve Therapeutics, Inc. (0001840574) (Filer)
Verve Therapeutics | 10-Q: Q3 2022 Earnings Report
Verve Therapeutics | 10-Q: Q2 2022 Earnings Report
Verve Therapeutics | 10-Q: Q1 2022 Earnings Report
Verve Therapeutics | 10-K: Annual report
Verve Therapeutics | 10-Q: Quarterly report
Verve Therapeutics | 10-Q/A: Quarterly report (Amendment)
Verve Therapeutics | 10-Q: Quarterly report
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg